Cobalefol Capsule
NDC Package 72835-550-01
Package Information
Cobalefol (vitamin) capsules is cobalefol is contraindicated in patients with a known hypersensitivity to any of the contained ingredients. This formulation utilizes a capsule delivery system. Marketed by V2 Pharma Llc, this product is identified by NDC 72835-550.
Identification & Billing
Clinical Specifications
- Analogs/Derivatives - [Chemical/Ingredient]
- Ascorbic Acid - [CS]
- Photoabsorption - [MoA] (Mechanism of Action)
- Photoenhancer - [EPC] (Established Pharmacologic Class)
- Photosensitizing Activity - [PE] (Physiologic Effect)
- Vitamin B 6 - [Chemical/Ingredient]
- Vitamin B6 Analog - [EPC] (Established Pharmacologic Class)
- Vitamin C - [EPC] (Established Pharmacologic Class)
- Vitamin D - [CS]
- Vitamin D - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 72835 - V2 Pharma Llc
- 72835-550 - Cobalefol
- 72835-550-01 - 30 CAPSULE in 1 BOTTLE
- 72835-550 - Cobalefol
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 72835-550-01 identifies a specific commercial package of 30 capsule in 1 bottle of Cobalefol, a human prescription drug labeled by V2 Pharma Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package. This capsule is formulated for oral use and contains .alpha.-tocopherol succinate, d-; ascorbic acid; cholecalciferol; folic acid; methylcobalamin; niacinamide; pyridoxine hcl; riboflavin 5'-phosphate; thiamine mononitrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by V2 Pharma Llc on May 16, 2025. The current certification is valid through December 31, 2026.
How is this V2 Pharma Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 72835055001. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.